Home/Filings/4/0001304492-25-000042
4//SEC Filing

Guttman-McCabe Christopher 4

Accession 0001304492-25-000042

CIK 0001304492other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 3:21 PM ET

Size

5.8 KB

Accession

0001304492-25-000042

Insider Transaction Report

Form 4
Period: 2025-05-20
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-20+53,49153,491 total
    Exercise: $34.96Exp: 2035-05-20Common Stock (53,491 underlying)
Footnotes (1)
  • [F1]The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1
  • filerCIK 0001828490

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 3:21 PM ET
Size
5.8 KB